Open Trial: METTSEO for Newly Diagnosed & Widely Metastatic Ewing Sarcoma

There is a new frontline strategy being tested for Ewing sarcoma patients with newly diagnosed & widely metastatic disease.

METTSEO takes inspiration from evolutionary biology and population dynamics. Instead of giving the tumor time to adapt to a predictable treatment pattern, the trial attempts to push cancer cells toward extinction through rapid, sequential changes in therapy.